P1RG34 Stock Overview
Provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Perrigo Company plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$148.27 |
| 52 Week High | US$154.05 |
| 52 Week Low | US$130.53 |
| Beta | 0.48 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -0.91% |
| 33 Year Change | -34.10% |
| 5 Year Change | n/a |
| Change since IPO | -40.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| P1RG34 | BR Pharmaceuticals | BR Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -1.3% |
| 1Y | -0.9% | -17.5% | -1.6% |
Return vs Industry: P1RG34 exceeded the BR Pharmaceuticals industry which returned -17.5% over the past year.
Return vs Market: P1RG34 matched the BR Market which returned -1.6% over the past year.
Price Volatility
| P1RG34 volatility | |
|---|---|
| P1RG34 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 8.6% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: P1RG34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine P1RG34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 9,140 | Patrick Lockwood-Taylor | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
| P1RG34 fundamental statistics | |
|---|---|
| Market cap | R$21.30b |
| Earnings (TTM) | -R$851.51m |
| Revenue (TTM) | R$25.46b |
0.8x
P/S Ratio-25.0x
P/E RatioIs P1RG34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P1RG34 income statement (TTM) | |
|---|---|
| Revenue | US$4.39b |
| Cost of Revenue | US$2.81b |
| Gross Profit | US$1.58b |
| Other Expenses | US$1.73b |
| Earnings | -US$146.90m |
Last Reported Earnings
Sep 28, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.08 |
| Gross Margin | 36.07% |
| Net Profit Margin | -3.34% |
| Debt/Equity Ratio | 104.8% |
How did P1RG34 perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield-103%
Payout RatioDoes P1RG34 pay a reliable dividends?
See P1RG34 dividend history and benchmarks| Perrigo dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Dec 23 2024 |
| Days until Ex dividend | 12 days |
| Days until Dividend pay date | 37 days |
Does P1RG34 pay a reliable dividends?
See P1RG34 dividend history and benchmarks